[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370600-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370600-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","computationally-integrating-radiology-and-pathology-image-features-for-predicting-treatment-benefit-and-outcome-in-lung-cancer","Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer","","Lung cancer causes substantial cancer-related mortality and lacks reliable predictive or prognostic biomarkers needed for accurate diagnosis and treatment selection. The study computationally integrates radiomics extracted from CT scans with pathomics derived from H&E pathology slides across three tasks: predicting recurrence in early-stage NSCLC, predicting immunotherapy response in advanced-stage NSCLC, and predicting chemotherapy response in SCLC. The integrated radio-pathomic model consistently outperforms standalone models and improves lung cancer risk stratification and treatment prediction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/computationally-integrating-radiology-and-pathology-image-features-for-predicting-treatment-benefit-and-outcome-in-lung-cancer/370600/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/computationally-integrating-radiology-and-pathology-image-features-for-predicting-treatment-benefit-and-outcome-in-lung-cancer/370600.png","ImageObject",300,407,{"name":42,"@type":43},"Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data sources were combined in the study?","Question",{"text":63,"@type":64},"Radiomics from CT scans and pathomics from H&E pathology slides were integrated to build predictive models.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which clinical prediction settings were evaluated?",{"text":68,"@type":64},"The work evaluated recurrence prediction in early-stage NSCLC, immunotherapy response prediction in advanced-stage NSCLC, and chemotherapy response prediction in SCLC.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the integrated model perform compared with individual models?",{"text":72,"@type":64},"The integrated radio-pathomic model significantly outperformed radiomic-only and pathomic-only models across the reported settings.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370600,1790902712,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","npj | precision oncology Article  \n\n| Published in partnership with The Hormel Institute, University of Minnesota |  | |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41698-025-00939-0](https://doi.org/10.1038/s41698-025-00939-0) |  |  |\n| Computationally integrating radiology and pathology image features for predicting treatment beneﬁt and outcome in\u003Cbr>lung cancer\u003Cbr> Check for updates |  |  |\n| PranjalVaidya1,8, Mohammadhadi Khorrami2,8, Kaustav Bera3, Pingfu Fu 4, Lukas Delasos5, Amit Gupta3, Cristian Barrera2, Nathan A. Pennell5, Vamsidhar Velcheti6 & Anant Madabhushi 2,7  |  |  |\n| Lung cancer, the leading cause of cancer-related deaths globally, includes non-small cell lung cancer (NSCLC) (85% of cases) and small cell lung cancer (SCLC) (13–15%) . While accurate diagnosis and treatment selection are critical, the absence of reliable predictive or prognostic biomarkers remains asigniﬁcant challenge. This study explored the combined use of radiomics from CT scans and pathomics from H&E slides in three contexts: (1) predicting disease recurrence in early-stage NSCLC,(2) predicting immunotherapy response in advanced-stage NSCLC, and (3) predicting chemotherapy response in SCLC. The integrated radio-pathomic model signiﬁcantly outperformed individual models. In early-stage NSCLC (N = 194), it achieved an HR of 8.35 (C-index: 0.71, p = 0.0043) . In advanced-stage NSCLC (N = 35), the combined model improved predictive performance (AUC: 0.75, p = 0.042) . In SCLC (N = 50), the integrated model showed an AUC of 0.78, surpassing both radiomicand pathomic models. These ﬁndings highlight the potential of combining radiomics and pathomics for improved lung cancer risk stratiﬁcation and treatment prediction. |  |  |\n| Lung cancer remains one of the leading causes of cancer-related mortality worldwide, and its complexity presents a signiﬁcant challenge for effective diagnosis and treatment. In particular, integrating diverse sources ofclinical data to create a more comprehensive understanding of the disease has become a key goal in modern oncology. By combining radiological imaging with pathological features, this study explores how such multimodal data can be integrated to create a more accurate predictive and prognostic marker. Lung cancer, with its well-documented heterogeneity and varying responses to treatment1,2, serves as an ideal case study to showcase the potential of this integrative approach. Our research speciﬁcally focuses on both non-small celllung cancer(NSCLC)and small cell lung cancer(SCLC), examining how radiomic and pathomic features can work together to improve risk stratiﬁcation and inform treatment decisions.\u003Cbr>Lung cancer’s clinical behavior varies signiﬁcantly depending on the stage of diagnosis and underlying tumor biology, necessitating tailored | strategies for early-stage and advanced disease. Early-stage NSCLC, which includes stage I or II disease according to the AJCC eighth edition TNM staging system3, is typically managed with surgical resection, with or without adjuvant therapy, depending on tumor characteristics and patient factors4,5. Despite curative surgery, 30–40% of stage I NSCLC patients experience recurrence within 5 years6. Survival rates differ by stage, with a 20% difference between stage IA and IB, suggesting that high-risk patients maybeneﬁt from adjuvant chemotherapy7. Unfortunately, major clinical trials have yielded inconsistent results regarding the beneﬁt of adjuvant chemotherapy in stage I NSCLC, underscoring the urgent need for novel biomarkers to improve risk stratiﬁcation and optimize adjuvant chemotherapy selection8–10.\u003Cbr>In advanced-stage NSCLC, including stage III and IV disease, outcomes remain poor despite recent advances. Historically, the 5-year overall survival rates for stage IV disease were just 1–8% with conventional |  |\n\n1Biomedical Engineering Department, Case Western Reserve University, Cleveland, USAOH. 2Wallace H. Coulter Department of Biomedical Engineering a","cbCaiczAfjJGnBju","https://ap.wps.com/l/cbCaiczAfjJGnBju","pdf",2043104,"English","# Abstract\n## Study goal and integration approach\n## Three prediction tasks and results\n## Clinical implications","[{\"question\":\"What data sources were combined in the study?\",\"answer\":\"Radiomics from CT scans and pathomics from H\\u0026E pathology slides were integrated to build predictive models.\"},{\"question\":\"Which clinical prediction settings were evaluated?\",\"answer\":\"The work evaluated recurrence prediction in early-stage NSCLC, immunotherapy response prediction in advanced-stage NSCLC, and chemotherapy response prediction in SCLC.\"},{\"question\":\"How did the integrated model perform compared with individual models?\",\"answer\":\"The integrated radio-pathomic model significantly outperformed radiomic-only and pathomic-only models across the reported settings.\"}]","Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer | PDF",1790189425,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/876058d0428c76718e2a7a5db8bb2fd5.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/115b059ecf55f42914062769ffbcb47c.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3caba491d73835874a56f36d1b1f85c7.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/296a3f5b2ef2b8d143f252e8dcb170f4.webp",980,1301]